Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
Latest action · Jul 17, 2018 Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedMar 19, 2018
- Passed HouseJul 16, 2018
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
This bill amends the Federal Food, Drug, and Cosmetic Act to substantially revise how over-the-counter (OTC) drugs are approved.
Cosponsors 8
Members who signed on, in the order they did. Signatures ran from Mar 19, 2018 to Jul 10, 2018; 5 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-KY | Brett Guthrie | Original | Mar 19, 2018 |
| D-MI | Debbie Dingell | Original | Mar 19, 2018 |
| D-CO | Diana DeGette | Original | Mar 19, 2018 |
| D-TX | Gene Green | Original | Mar 19, 2018 |
| R-TX | Michael C. Burgess | Original | Mar 19, 2018 |
| D-CA | Doris O. Matsui | May 15, 2018 | |
| R-TN | Charles J. "Chuck" Fleischmann | May 18, 2018 | |
| D-OR | Kurt Schrader | Jul 10, 2018 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Mar 19, 2018Markup May 9, 2018Reported Jul 16, 2018 |
| Health Subcommittee | Referred Mar 23, 2018 |
Actions 13
Everything that happened, newest first.
- Jul 17, 2018Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 518.
- Jul 16, 2018Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 115-827.
- Jul 16, 2018Placed on the Union Calendar, Calendar No. 640.
- Jul 16, 2018Mr. Latta moved to suspend the rules and pass the bill, as amended.
- Jul 16, 2018Considered under suspension of the rules. (consideration: CR H6227-6237)
- Jul 16, 2018DEBATE - The House proceeded with forty minutes of debate on H.R. 5333.
- Jul 16, 2018Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H6227-6235)
- Jul 16, 2018Motion to reconsider laid on the table Agreed to without objection.
- May 9, 2018Committee Consideration and Mark-up Session Held.
- May 9, 2018Ordered to be Reported (Amended) by Voice Vote.
- Mar 23, 2018Referred to the Subcommittee on Health.
- Mar 19, 2018Introduced in House
- Mar 19, 2018Referred to the House Committee on Energy and Commerce.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| House | Debate and remarks H6227–H6237Text printed H6227–H6235 | Debbie Dingell D-MI, Diana DeGette D-CO, Earl L. "Buddy" Carter R-GA, Gene Green D-TX, Michael C. Burgess R-TX, Robert E. Latta R-OH | Jul 16, 2018 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Committee report
Congressional Budget Office cost estimate
- Jun 8, 2018H.R. 5333, Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018As ordered reported by the House Committee on Energy and Commerce on May 9, 2018
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 164, no. 47, March 19, 2018, page H1698.
Related bills 2
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2315 | Over-the-Counter Drug Safety, Innovation, and Reform Act | Related bill | May 14, 2018 |
| HR 7328 | Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2018 | Related bill | Dec 20, 2018 |
Titles 7
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act to clarify the regulatory framework with respect to certain nonprescription drugs that are marketed without an approved new drug application, and for other purposes.
- Short Titles as Introduced
- Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
- Short Titles as Reported to House
- Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
- Short Titles as Passed House
- Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2018
- Short Titles as Introduced for portions of this bill
- Over-the-Counter Monograph User Fee Act of 2018
- Short Titles as Reported to House for portions of this bill
- Over-the-Counter Monograph User Fee Act of 2018
- Short Titles as Passed House for portions of this bill
- Over-the-Counter Monograph User Fee Act of 2018
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 4
Each version as it was printed, newest first.
- Jul 17, 2018Placed on Calendar Senate
- Jul 16, 2018Reported in House
- Jul 16, 2018Engrossed in House
- Mar 19, 2018Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.